Q3 2023 Marksans Pharma Ltd Earnings Call Transcript
Good evening, everyone, and a warm welcome to Marksans Pharma's Q3 and nine-months FY23 earnings call. (Operator Instructions) The results, press release, and investor presentation are available on the stock exchanges and company website.
I would like to now introduce the management team today on the call with us: Mr. Mark Saldanha, Founder, Chairman, and Managing Director; and Mr. Jitendra Sharma, Chief Financial Officer. A cautionary note that some of the statements made on today's call could be forward-looking in nature and actual results could vary from these statements. A detailed intimation in this regard is available in the Investor Presentation, which is available on the stock exchanges and the company's website.
I will now hand over the call to Mr. Mark Saldanha for the highlights. Over to you, sir.
Thank you, Siddharth. Welcome, everyone, and thank you for joining us on our Q3 FY23 and nine-month FY23 earning conference call. I'm pleased to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |